These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 18165968)
1. Identification of pharmacogenetic markers in smoking cessation therapy. Heitjan DF; Guo M; Ray R; Wileyto EP; Epstein LH; Lerman C Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):712-9. PubMed ID: 18165968 [TBL] [Abstract][Full Text] [Related]
2. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993 [TBL] [Abstract][Full Text] [Related]
8. [Bupropion. An antidepressant used to help smoking cessation]. Taeron C Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615 [No Abstract] [Full Text] [Related]
9. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730 [TBL] [Abstract][Full Text] [Related]
10. The "bupropion for smoking cessation" trial from a family practice perspective. Caplan BJ Arch Intern Med; 2005 Feb; 165(4):470. PubMed ID: 15738382 [No Abstract] [Full Text] [Related]
11. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292 [TBL] [Abstract][Full Text] [Related]
12. Helping smokers quit through pharmacogenetics. Lerman C LDI Issue Brief; 2006; 11(6):1-4. PubMed ID: 16827222 [TBL] [Abstract][Full Text] [Related]
13. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753 [TBL] [Abstract][Full Text] [Related]
15. Smoking cessation interventions for smokers with current or past depression. van der Meer RM; Willemsen MC; Smit F; Cuijpers P Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776 [TBL] [Abstract][Full Text] [Related]